Crossmark

COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy

Published Online: 2020-08-27

Published Print: 2020-10

Authors

Vitiello, Antonio

Pelliccia, Chiara

Ferrara, Francesco https://orcid.org/0000-0001-9298-6783
License Information

Text and Data Mining valid from 2020-08-27

Version of Record valid from 2020-08-27
More Information

Article History

Accepted: 24 August 2020

First Online: 27 August 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Free to read: This content has been made available to all.

Document is current